PMID: 6978679Jan 1, 1981Paper

Electrical stimulation of the spinal cord and peripheral nerves for pain control. A 10-year experience

Applied Neurophysiology
D M LongR B North

Abstract

Patients who underwent implantation of dorsal column stimulators from 1970 to 1973 were reviewed 7-10 years following stimulation. The number who achieved satisfactory pain relief was not significant. The criteria for selecting these patients were reviewed utilizing those now used in 1980. 50% of the patients originally selected would now be rejected for psychological or drug-related reasons. This long-term evaluation indicates no benefit to the patients treated with spinal cord stimulation. However, it appears that psychological factors were the most important reasons for failure. A smaller group of patients studied for 3-5 years following implantation of epidural spinal cord stimulators achieved a 70% pain control rate. Selection factors that explain these differences are discussed.

Citations

Feb 1, 1986·Journal of Neurology·H P VogelC Wagner
Mar 1, 2012·Translational Behavioral Medicine·Randy S RothDavid A Williams
May 1, 1989·Current Problems in Cancer·R B Patt, S Jain
Jan 1, 1984·Progress in Neuro-psychopharmacology & Biological Psychiatry·D J Mayer
Jan 1, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Konstantin V Slavin
Oct 1, 2000·Neuromodulation : Journal of the International Neuromodulation Society·K M Aló, A M Zidan
Oct 1, 1998·Neuromodulation : Journal of the International Neuromodulation Society·R B NorthP N Cutchis
Jan 1, 1998·Neuromodulation : Journal of the International Neuromodulation Society·K A OlsonM R Villanueva
Jan 1, 1998·Neuromodulation : Journal of the International Neuromodulation Society·K M AloV Redko
Jan 1, 2009·Neuromodulation : Journal of the International Neuromodulation Society·Paul VerrillsChantelle Sinclair
Jan 1, 2009·Neuromodulation : Journal of the International Neuromodulation Society·Paul VerrillsChantelle Sinclair
Apr 1, 2009·Neuromodulation : Journal of the International Neuromodulation Society·Elliot KramesRobert Levy
Oct 14, 2011·Neuromodulation : Journal of the International Neuromodulation Society·Elliot S KramesRobert Levy
Mar 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·B A Simpson
Sep 21, 2012·Journal of Neurophysiology·David BoinagrovDaniel Palanker
Apr 1, 1989·Journal of Neurosurgery·M MeglioG F Rossi
Jul 6, 2000·Journal of Neurosurgery·O Sagher, D L Huang
Feb 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·E Van de Kelft, C De La Porte
Jul 30, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·James CelestinRobert N Jamison
Apr 25, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Hubert PolácekAndrej Stancák
Feb 28, 2013·Neuromodulation : Journal of the International Neuromodulation Society·Lawrence PoreeLouise Schultz
Feb 1, 1987·Acta Neurologica Scandinavica·K Wester
Sep 22, 2000·Current Review of Pain·L Lou
Dec 19, 2006·Pain Practice : the Official Journal of World Institute of Pain·Diego BeltruttiRonald Melzack
Jul 1, 1986·Pacing and Clinical Electrophysiology : PACE·D ShatinG Hults
Aug 18, 2020·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Einar Ottestad, Daniel S Orlovich
Jul 5, 2016·Neuromodulation : Journal of the International Neuromodulation Society·Bruce MitchellChantelle Sinclair

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.